Objectives-The aim of this study was to evaluate the long term effect of radiation synovectomy with yttrium-90 silicate in haemophiliac patients with recurrent haemarthrosis. Methods-The bleeding frequency and the mobility of the joint were recorded in 16 joints of 14 patients 1 year before radiosynovectomy and during follow up, which ranged from 3 to 6 years. Patients evaluated the effect of their own treatment by completing a questionnaire. Radiographs of the joints were scored by an independent radiologist before treatment.
Results-A satisfactory reduction of the frequency of haemorrhage was achieved in 94% of joints during the first year after treatment and was maintained in 63% until the end of the follow up period. In general there was no decrease in mobility attributable to radiosynovectomy, and the patients' own evaluations agreed with the evaluations based on the frequencies of haemarthrosis in 75%. Patients who had only minor, or no, radiological abnormalities of the joints before treatment showed the best results. One patient developed synovitis as a complication of the radiosynovectomy. by an independent radiologist. Patients completed a questionnaire at the end of follow up in which they were asked about the effect of radiosynovectomy on the frequency of bleeding, pain, articular mobility, and activities of daily living.
Conclusion-Radiosynovectomy is
The clotting deficiency was corrected before treatment and during the following three days in order to reach clotting factor activity of 50%.
Before intra-articular administration of 90Y contrast fluid was injected into the joint under radiographic control to ensure that the needle was correctly positioned.6 The dosage of 90Y was 2 mCi (74 MBq) for the wrist, elbow, and ankle and 5 mCi (185 MBq) for the knee. Within 24 hours after the injection, frontal and lateral scintigraphy were performed to check the distribution of the radioactive material in the joint. Following injection, the joint was immobilised by an elastic bandage and patients were confined to bed for 3 days. The frequency of haemarthrosis during the first and third year after treatment was compared with that which occurred during the year before radiosynovectomy. The average frequency of haemarthrosis during the follow up period was also assessed. The outcome was considered good if haemarthrosis decreased by 50-100%, moderate when the decrease was 25-49%, and failure when there was a reduction of less than 25%. The results of the questionnaire were also classified in similar terms. 14 The total body radiation load due to leakage of 90Y in the knee joint was calculated to be 0-8 cGy,6 (the inguinal nodes and knee joint excluded), which is comparable with the effective dose equivalent of urography (1-8 cGy).'5 After 30 years of radiosynovectomy treatment in rheumatology, no increased incidence of cancer or congenital abnormalities has been reported. On the other van Kasteren, Novakova, Boerbooms, Lemmens hand, the advantages of radiosynovectomy over surgical synovectomy include a shorter stay in hospital, less requirement for clotting factor, shorter rehabilitation, no anaesthesia, no increase of joint mobility, and the simplicity of the procedure, making it an attractive method of treatment of recurrent bleedings in haemophiliac patients.
Department of
Our data suggest that radiation synovectomy is an effective and safe treatment of recurrent articular bleeding in haemophiliac patients, especially in joints with no or minor radiological damage.
